Beta Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
BETA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beta Drugs Limited's Registrar and Transfer Agent (RTA), MUFG Intime India Private Limited, has submitted a quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended 30th June 2025. The certificate confirms that all securities received from depository participants for dematerialisation during the quarter were properly processed, confirmed or rejected, and listed on the stock exchanges. It also confirms that physical share certificates received for demat were mutilated, cancelled, and replaced with the depository's name in the company's register of members within the required timelines. This is a standard regulatory filing required from the RTA every quarter.
This is a routine procedural compliance filing with no material impact on the company's financials, operations, or stock price. Shareholders need not take any action as the filing only relates to the proper processing of demat requests during the quarter.